APA

Feun L. G., Marini A., Walker G., Elgart G., Moffat F., Rodgers S. E., Wu C. J., You M., Wangpaichitr M., Kuo M. T., Sisson W., Jungbluth A. A., Bomalaski J. & Savaraj N. (20120619). Negative argininosuccinate synthetase expression in melanoma tumours may predict clinical benefit from arginine-depleting therapy with pegylated arginine deiminase. : British journal of cancer.

Chicago

Feun L G, Marini A, Walker G, Elgart G, Moffat F, Rodgers S E, Wu C J, You M, Wangpaichitr M, Kuo M T, Sisson W, Jungbluth A A, Bomalaski J and Savaraj N. 20120619. Negative argininosuccinate synthetase expression in melanoma tumours may predict clinical benefit from arginine-depleting therapy with pegylated arginine deiminase. : British journal of cancer.

Harvard

Feun L. G., Marini A., Walker G., Elgart G., Moffat F., Rodgers S. E., Wu C. J., You M., Wangpaichitr M., Kuo M. T., Sisson W., Jungbluth A. A., Bomalaski J. and Savaraj N. (20120619). Negative argininosuccinate synthetase expression in melanoma tumours may predict clinical benefit from arginine-depleting therapy with pegylated arginine deiminase. : British journal of cancer.

MLA

Feun L G, Marini A, Walker G, Elgart G, Moffat F, Rodgers S E, Wu C J, You M, Wangpaichitr M, Kuo M T, Sisson W, Jungbluth A A, Bomalaski J and Savaraj N. Negative argininosuccinate synthetase expression in melanoma tumours may predict clinical benefit from arginine-depleting therapy with pegylated arginine deiminase. : British journal of cancer. 20120619.